Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors

Clinical evidence suggests that antibodies from reconvalescent donors (persons who have recovered from infection) may be effective in the treatment of Ebola virus infection. Administration of this treatment to Ebola virus–infected patients while preventing the transmission of other pathogenic viruse...

Descripción completa

Detalles Bibliográficos
Autor principal: Kreil, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2015
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344290/
https://www.ncbi.nlm.nih.gov/pubmed/25695274
http://dx.doi.org/10.3201/eid2103.141838
_version_ 1782359398421626880
author Kreil, Thomas R.
author_facet Kreil, Thomas R.
author_sort Kreil, Thomas R.
collection PubMed
description Clinical evidence suggests that antibodies from reconvalescent donors (persons who have recovered from infection) may be effective in the treatment of Ebola virus infection. Administration of this treatment to Ebola virus–infected patients while preventing the transmission of other pathogenic viruses may be best accomplished by use of virus-inactivated reconvalescent plasma.
format Online
Article
Text
id pubmed-4344290
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-43442902015-03-02 Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors Kreil, Thomas R. Emerg Infect Dis Dispatch Clinical evidence suggests that antibodies from reconvalescent donors (persons who have recovered from infection) may be effective in the treatment of Ebola virus infection. Administration of this treatment to Ebola virus–infected patients while preventing the transmission of other pathogenic viruses may be best accomplished by use of virus-inactivated reconvalescent plasma. Centers for Disease Control and Prevention 2015-03 /pmc/articles/PMC4344290/ /pubmed/25695274 http://dx.doi.org/10.3201/eid2103.141838 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Kreil, Thomas R.
Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title_full Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title_fullStr Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title_full_unstemmed Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title_short Treatment of Ebola Virus Infection with Antibodies from Reconvalescent Donors
title_sort treatment of ebola virus infection with antibodies from reconvalescent donors
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344290/
https://www.ncbi.nlm.nih.gov/pubmed/25695274
http://dx.doi.org/10.3201/eid2103.141838
work_keys_str_mv AT kreilthomasr treatmentofebolavirusinfectionwithantibodiesfromreconvalescentdonors

Ejemplares similares